| 5 | 1/1 | 返回列表 |
| 查看: 2374 | 回復: 26 | |||
| 當前主題已經(jīng)存檔。 | |||
| 當前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | |||
johnzhl01鐵桿木蟲 (著名寫手)
|
[交流]
《創(chuàng)新藥物化學》英文原版下載
|
||
|
書名 Practice of Medicinal Chemistry, 2nd ed ISBN-10 0-12-744481-5 作者 C. Wermuth, ed. 出版社 Academic Press, 2003, 624 pp., hard cover 目錄 A Brief History Of Drugs; From Plant Extracts To DNA Technology. Medicinal Chemistry: Definition And Objectives, The Three Main Phases Of Drug Activity, Drug And Diseases Classifications. Measurement And Expression Of Drug Effects. Drug Targets: Molecular Mechanisms Of Drug Action. Strategies In The Search For New Lead Compounds Or Original Working Hypotheses. Natural Products As Pharmaceuticals And Sources For Lead Structures. Basics Of Combinatorial Chemistry. The Contribution Of Molecular Biology To Drug Discovery. Electronic Screening: Lead Finding From Database Mining. High-Speed Chemistry Libraries: Assessment Of Drug-Likeness. Web Alert - Using The Internet For Medicinal Chemistry. Molecular Variations In Homologous Series: Vinylogues And Benzologues. Molecular Variations Based On Isosteric Replacements. Ring Transformations. Introduction Of Conformational Restriction And/Or Steric Hindrance. Identical And Non Identical Twin Drugs. Optical Isomerism In Drugs. Application Strategies For The Primary Structure-Activity Relationship Exploration. Specific Substituent Groups. The Role Of Functional Groups In Drug–Receptor Interactions. Compound Properties And Drug Quality. Quantitative Approaches To Structure-Activity Relationships. Structural Aspects Of Drug Action I. Pharmacophore Identification And Receptor Mapping. Three-Dimentional Quantitative Structure-Property Relationships. Protein Crystallography And Drug Discovery. Protein Comparative Modelling And Drug Discovery. The Transition From Agonist To Antagonist Activity: Symmetry And Other Considerations. Design Of Peptidomimetics. The Fate Of Xenobiotics In Living Organisms. Biotransformation Reactions. Chemical Mechanisms Of Toxicity. Basic Knowledge For Designing Safer Drugs. Designing Prodrugs And Bioprecursors. Macromolecular Carriers For Drug Targeting. Preparation Of Water Soluble Compounds Through Salt Formation. Preparation Of Water-Soluble Compounds By Covalent Attachment Of Solubilizing Moieties. Drug Solubilization With Organic Solvents, Surfactants And Lipids. Improvement Of Drug Properties By Cyclodextrins. Chemical And Physicochemical Solutions To Formulation Problems. Discover A Drug Substance, Formulate And Develop It To A Product. Drug Nomenclature. Legal Aspects Of Product Protection. The Consumption And Production Of Pharmaceuticals. 下載鏈接: http://a.thec.cn/fwangj/practice_of_medicinal_chemistry.pdf [ Last edited by johnzhl01 on 2007-5-19 at 18:16 ] |

至尊木蟲 (著名寫手)
木蟲 (著名寫手)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿西交288化工專碩求調(diào)劑 +4 | 好運好運接接 2026-03-24 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 313求調(diào)劑 +3 | 賣個關子吧 2026-03-31 | 3/150 |
|
|
[考研] 求調(diào)劑,一志愿 南京航空航天大學 ,080500材料科學與工程學碩,總分289分 +9 | @taotao 2026-03-29 | 9/450 |
|
|
[考研] 288資源與環(huán)境專碩求調(diào)劑,不限專業(yè),有學上就行 +11 | lllllos 2026-03-30 | 11/550 |
|
|
[考研] 材料科學與工程 317求調(diào)劑 +7 | JKSOIID 2026-03-26 | 7/350 |
|
|
[考研] 327求調(diào)劑 +5 | 小卡不卡. 2026-03-29 | 5/250 |
|
|
[考研] 332求調(diào)劑 +6 | @MZB382400 2026-03-28 | 6/300 |
|
|
[考研] 求調(diào)劑 +7 | 青春裁為三截 2026-03-29 | 7/350 |
|
|
[考研] 0703本科鄭州大學求調(diào)劑 +7 | nhj_ 2026-03-25 | 7/350 |
|
|
[考研] 352分-085602-一志愿985 +5 | 海納百川Ly 2026-03-29 | 5/250 |
|
|
[考研] 298求調(diào)劑 +4 | 種圣賜 2026-03-28 | 4/200 |
|
|
[考研] 數(shù)一英一271專碩(085401)求調(diào)劑,可跨 +7 | 前行必有光 2026-03-28 | 8/400 |
|
|
[考研] 11408軟件工程求調(diào)劑 +3 | Qiu學ing 2026-03-28 | 3/150 |
|
|
[考研] 286求調(diào)劑 +4 | 丟掉懶惰 2026-03-27 | 7/350 |
|
|
[考研] 085600,材料與化工321分調(diào)劑 +4 | 大饞小子 2026-03-27 | 6/300 |
|
|
[考研] 348求調(diào)劑 +4 | 小懶蟲不懶了 2026-03-27 | 5/250 |
|
|
[考研] 298調(diào)劑 +3 | jiyingjie123 2026-03-27 | 3/150 |
|
|
[考研] 調(diào)劑 +3 | 李嘉圖·S·路 2026-03-27 | 3/150 |
|
|
[考研] 一志愿吉大071010,316分求調(diào)劑 +3 | xgbiknn 2026-03-27 | 3/150 |
|
|
[考研] 290分調(diào)劑求助 +3 | 吉祥止止陳 2026-03-25 | 3/150 |
|